主要从事儿童消化感染性疾病诊疗,以及肠道微生态与肠道免疫研究。2013年率先开展儿童粪菌移植(FMT),成功完成了全国首例儿童FMT治疗儿童重症伪膜性肠炎,并建立儿童FMT治疗规范,提高儿童艰难梭菌感染的治愈率。为FMT治疗儿童艰难梭菌感染提供重要循证医学证据。2016年建立上海首个公益性母乳库,有效降低了本院早产儿坏死性小肠结肠炎的发生率,获得母乳益生菌国家发明专利1项。经过多年对于肠道菌群、FMT及儿童疾病关系的临床与科研实践,2013年至今主持各级项目38项,国家自然科学基金2项,包括多项省部级、局级项目。已发表科研论文166篇,其中SCI收录论文92篇,总SCI影响因子达342分。参编著作9部。包括:Microb Cell Fact, J Transl Med,Am J Pathol, J Leuko Biol, Sci Rep和J Crohns Colitis等。 近5年发表论文列表: 1. Pei Xiao, Youran Li, Xiaolu Li, Ting Ge, Dan Li, Qiao Xu, Yangming Ruan, Fangfei Xiao, Yongmei Xiao, Ting Zhang*. Long-term safety of faecal microbiota transplantation in Chinese children from 2013 to 2023: A single-center retrospective study, BMC Microbiology.2025; 25(1):152. (IF: 4.06 JCR Q2) 2. Pei Xiao, Ting Song, Xiaolu Li, Yongmei Xiao, Ruixue Wang, Feifei Song, Dan Li, Aihua Zhang, Ying Wang, Ting Zhang*, Effects of dietary fiber on Chinese children with functional constipation and targeted modification of gut microbiota and related metabolites. Frontiers in nutrition, 2025 Jul 14:12:1579668 (IF: 4.95 JCR Q1). 3. Rong Cao,Cuili Xue,Xiaolu Li,Fangfei Xiao,Lin Ye,Xufei Wang,Yizhong Wang,Daxiang Cui, Ting Zhang*, Profiling of Volatile Organic Compounds in Clinical Isolate Cultures and Stools from Children with Clostridioides difficile Infection by HS-SPME-GC-MS. J Breath Res. 2025 Oct 7;19(4) (IF: 3.51 JCR Q2). 4. Runjie Wang, Ruixue Wang, Yongmei Xiao, Xiaolu Li, Ting Ge, Ronghua Yu, Ting Song, Chenling Yuan, Ting Zhang*. Intestinal Methanogen Overgrowth and Its Impact on Gastrointestinal Disorders in Children: A Retrospective Study. BMC Gastroenterol. 2025;25(1):848 (IF: 2.67 JCR Q2) 5. Yuexiao Tao, Zhenyan Jiang, Huizi Wang, Jia Li , Xin Li, Jun Ni, Jiamin Liu, Hongrui Xiang, Chenyang Guan, Wei Cao, Dongyang Li, Ke He, Lina Wang, Jing Hu, Ying Jin, Bing Liao, Ting Zhang*, Xuefeng Wu. Pseudokinase STK40 promotes TH1 and TH17 cell differentiation by targeting FOXO transcription. Sci Adv. 2024;10(47):eadp2919. (IF: 11.7 JCR Q1) 6. Xiaolu Li, Yizhong Wang, Rong Cao, Fangfei Xiao, Xufei Wang, Lin Ye, Yongmei Xiao, Dan Li, Ting Zhang*. Antimicrobial Resistance of Clostridioides difficile in Children from a Tertiary Pediatric Hospital in Shanghai, China. Infect Drug Resist. 202426:17:329-339(IF: 2.9) 7. Xufei Wang, Fang Dong, Gaojie Liu, Lin Ye, Fangfei Xiao, Xiaolu Li, Ting Zhang, Yizhong Wang*,Probiotic properties and the ameliorative effect on DSS-induced colitis of human milk-derived Lactobacillus gasseri SHMB 0001.J Food Sci. 2024;89(5):3078-3093(IF: 3.2). 8. Youran Li, Pei Xiao, Rong Cao, Jun Le, Qiao Xu, Fangfei Xiao, Lin Ye, Xufei Wang, Yizhong Wang, Ting Zhang*. Effects and microbiota changes following oral lyophilized fecal microbiota transplantation in children with autism spectrum disorder.Front Pediatr. 2024 May 9;12:1369823(IF: 2.1). 9. Ye L, Wang Y, Xiao F, Wang X, Li X, Cao R, Zhang J, Zhang T*. F. prausnitzii-derived extracellular vesicles attenuate experimental colitis by regulating intestinal homeostasis in mice. Microb Cell Fact. 2023 Nov 15;22(1):235. (IF: 6.4) 10. Xiaolu Li, Fangfei Xiao, Xufei Wang, Lin Ye, Yongmei Xiao, Dan Li, Ting Zhang, Yizhong Wang. Gut Microbial and Metabolic Features Associated with Clostridioides difficile Infection Recurrence in Children. Open Forum Infect Dis. 2024;11(9):ofae506(IF: 3.8JCR Q2). 11. Wang, Y., Zhou, J., Lu, Y., Hu, H., Xiao, F., Ge, T., Wang, X., Zheng, L., Yu, L. H., Le, J., Yu, H., Yu, G. J., Xia, Q., Zhang, T.*, & Zhou, W. Altered gut microbiota composition in children and their caregivers infected with the SARS-CoV-2 Omicron variant. World journal of pediatrics, (2023). 19(5), 478–488. (JCR Q1,IF: 8.7) 12. Wang Y, Liu H, Dong F, Xiao Y, Xiao F, Ge T, Li D, Yu G, Zhang T*. Altered gut microbiota and microbial metabolism in children with hepatic glycogen storage disease: a case-control study. Transl Pediatr. 2023 Apr 29;12(4):572-586. (IF: 2) 13. Xiao FF., Dong F., Li XL., Li YR., Yu GJ., Liu ZJ, Wang, YZ, Zhang T.*. Bifidobacterium longum CECT 7894 improves the efficacy of infliximab for DSS-induced colitis via regulating the gut microbiota and bile acid metabolism.Front Pharmacol. 2022; in press. (IF: 5.988) 14. Dong F., Xiao FF., Li XL., Li YR., Wang XF., Yu GJ., Zhang T. *, Wang, YZ. Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice. J Transl Med. 2022; 20:33. (IF: 8.440) 15. Xiao, F., Gao, X., Hu, H., Le, J., Chen, Y., Shu, X., Liang, Z., Xu, Y., Wang, Y., & Zhang, T*. Exclusive Enteral Nutrition Exerts Anti-Inflammatory Effects through Modulating Microbiota, Bile Acid Metabolism, and Immune Activities. Nutrients, (2022)14(21), 4463. (JCR Q1,IF: 6.706) 16. Wang YZ., Gao XF., Zhang XY., Xiao FF., Hu H., Li XL., Dong F., Sun MM., Xiao YM., Ge T., Li D., Yu GJ., Liu ZJ., and Zhang T.*.Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn’s disease.Gut Microbes. 2021; 13 (1): 1-18.(IF=9.434) 17. 牟娅妮,宋雪,李小露,张婷*;儿童百日咳临床诊疗的单中心回顾性研究,国际流行病学传染病学杂志,2025,52(3):166-171 18. 涂乐文,李小露,王怡仲, 张婷*. 胆汁酸与艰难梭菌感染研究进展, 国际儿科学杂志, 2025,52(3): 155-159 19. 刘高杰,王续霏,王怡仲, 张婷*. 鼠李糖乳酪杆菌GG在儿童消化系统疾病中的应用进展, 国际儿科学杂志, 2025,52(1): 1-5 20. 梅永超, 张婷*. 人乳中活性成分的潜在价值、应用现状及其面临的挑战, 上海医药, 2025,46(3): 6-9,69 21. 曹荣,李小露,王怡仲,张婷*,儿童艰难梭菌感染临床疗效分析. 医学研究杂志, 2024; 2(6): 56-61. 22. 刘红红,王怡仲,肖咏梅,吴胜男,张育才,张婷*. 基因突变致LIG4综合征临床及基因特征. 中国实用儿科杂志, 2024; 7(9): 530-538. 23. 王星, 葛婷, 周韬, 夏强,卢燕鸣,王立波, 张婷* . KMT2D基因变异致歌舞伎综合征合并胆道闭锁 1例[J]. 中华儿科杂志,2023, 61(2): 180-181. 24. 葛婷, 王怡仲, 张婷*. 儿童炎症性肠病与口腔微生物的关系 [J] . 国际儿科学杂志, 2023, 50(3) : 186-189. 25. 李小露,张婷*.儿童艰难梭菌感染治疗进展与对策[J].上海医学,2023,46(7):439 -443 近5年主持课题情况: 1. 普拉梭菌胞外囊泡msRNA跨界调控MAPK/NF-κB/NLRP3轴抑制肠上皮细胞 焦亡改善克罗恩病的作用机制研究,国自然面上项目,8247031679,2025.1.1-2028.12.31,49万,主持,在研 2. 布拉氏酵母菌散预防婴幼儿抗生素相关性腹泻临床研究,横向临床研究课题,HXIIT202502,2025.5.-2026.12,20万,主持,在研 3. 基于信息化的儿科感染性疾病质量控制体系的探索,上海申康医院发展中心技术规范化管理和推广项目,SHDC22024253,2024/06-2026/05,10万,主持,在研 4. 肠菌移植治疗儿童孤独症,上海科学技术委员会—2022 年度“科技创新行动计划”医学创新研究专 项 ,2022/07-2025/06,30 万,主持,在研 5. 基于金属纳米颗粒的艰难梭菌特异性挥发有机物传感器的研制,上海交通大学医工交叉重点项目YG2022ZD022,2021/01-2024/12,100 万,主持,在研 6. 肠道共生菌F.prausnitzii胞外囊泡促进Treg细胞分化抑制IBD肠道炎症的机制研究,国家自然科学基 金面上项目,81870373,2019/01-2022/12,57万,主持,已结题 7. 肠内营养联合饮食干预诱导克罗恩病患儿粘膜愈合的前瞻性研究,上海市卫生健康委卫生行业临床 研究专项面上项目,202040479,2021/01-2023/12,10万,主持,已结题